Metastatic Breast Cancer Awareness Day: What You Need to Know

For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space.
BY Jessica Skarzynski
PUBLISHED October 13, 2019
For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space:

  1. Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE to discuss her experiences with non-Hodgkin lymphoma, then stage 2 breast cancer and, most recently, metastatic stage 4 breast cancer.
  2. After being  diagnosed with metastatic breast cancer in January 2015, CURE contributor Martha Carlson shares some tips on how to responsibly search for healthcare information online.
  3. The Food and Drug Administration recently approved Piqray (alpelisib) for the treatment of certain postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer.
  4. Eight-year metastatic “thriver” Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.
  5. In another FDA action, the subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy was approved for the treatment of select patients with breast cancer.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Breast Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In